Search Results

E Merck funding plan

• Source: The Times (London, England). April 10, 1995, p41.

Record details

E Merck funding plan.

• Source: The Times (London, England). 1995, pages. 41

Record details

Merck KGAA.

• Source: The Wall Street Journal Western Edition. 1995.

Record details

VWR COMPLETES ACQUISITION OF BAXTER'S INDUSTRIAL AND LIFE SCIENCES DIVISION

• Source: PR Newswire. Sept 15, 1995, p915NY030

Record details

VWR COMPLETES ACQUISITION OF BAXTER'S INDUSTRIAL AND LIFE SCIENCES DIVISION

• Source: PR Newswire. 1995.

Record details

VWR COMPLETES ACQUISITION OF BAXTER'S INDUSTRIAL AND LIFE SCIENCES DIVISION

Record details

Merck KGaA aims for top in generics

Subjects: Merck KGaA -- Management; Management; Marketing

• Source: SCRIP World Pharmaceutical News. Sept 22, 1995 Issue 2062, p12, 1 p.

Record details

Merck KGaA boosts R&D spend

Subjects: Merck KGaA -- Research; Research; Pharmaceutical industry -- Research

• Source: SCRIP World Pharmaceutical News. Sept 26, 1995 Issue 2063, p11, 1 p.

Record details

Chemical giant Merck plans to tap market for $1.5-billion 327-year-old company plans Germany's largest postwar stock offering

Record details

Chemical giant Merck plans to tap market for $1.5-billion 327-year-old company plans Germany's largest postwar stock offering.

• Source: Globe & Mail (Toronto, Canada), Oct 17, 1995. P. B11

Record details

Price set for Merck offer.

• Authors : Miller, John H.

• Source: The Wall Street Journal Western Edition. 1995, pages. ) 17(

Record details

Merck IPO is heavily oversubscribed as partial float raises $1.47 billion

• Source: Wall Street Journal. Europe. Oct 17, 1995, Vol. 13, Issue 181, p14, 1 p.

Record details

Merck IPO is heavily oversubscribed as partial float raises $1.47 billion

Subjects: Merck KGAA -- Finance; Pharmaceutical industry -- Finance; Banking, finance and accounting industries

• Source: Wall Street Journal. Europe. Oct 17, 1995, Vol. 13 Issue 181, p14, 1 p.

Record details

Merck IPO is heavily oversubscribed as partial float raises $1.47 billion.

• Source: Wall Street Journal. Europe. 1995, Vol. v13, Issue n181, pages. 1

Record details

Merck KGaA cuts 1995 sales forecast

Subjects: Merck KGaA -- Finance; Finance; Pharmaceutical industry -- Finance

• Source: SCRIP World Pharmaceutical News. Dec 15, 1995 Issue 2086, p9, 1 p.

Record details

Mixed European results

• Source: Chemical Week. January 31, 1996, Vol. 158, Issue 4, p7, 1 p.

Record details

Mixed European results.

• Source: Chemical Week. 1996, Vol. 158, Issue 4, pages. 1

Record details

First 7-day HRT patches in UK

Subjects: Merck KGaA -- Product introduction; Bayer HealthCare Pharmaceuticals -- Product introduction -- 00137275; FemSeven (Transdermal patch) -- Product introduction

• Source: SCRIP World Pharmaceutical News. Feb 9, 1996 Issue 2101, p16, 1 p.

Record details

Merck KGaA's new psoriasis ointment

Subjects: Merck KGaA -- Product introduction; Drug therapy; Product introduction

• Source: SCRIP World Pharmaceutical News. Feb 23, 1996 Issue 2105, p21, 1 p.

Record details

Very briefly

• Source: International Herald Tribune. March 8, 1996 p13.

Record details

Very briefly:.

• Source: International Herald Tribune. 1996, pages. 13

Record details

Very briefly

• Source: International Herald Tribune. April 17, 1996 p15.

Record details

Merck KGaA buys Roche unit.

• Source: The Wall Street Journal Western Edition. 1996.

Record details

SMITHKLINE BEECHAM, HUMAN GENOME SCIENCES, AND MERCK KGAA SIGN MEMORANDUM OF INTENT FOR GENOMICS AGREEMENT

• Source: PR Newswire. April 18, 1996, p418PHTH010

Record details

SMITHKLINE BEECHAM, HUMAN GENOME SCIENCES, AND MERCK KGAA SIGN MEMORANDUM OF INTENT FOR GENOMICS AGREEMENT

• Source: PR Newswire. 1996.

Record details

SMITHKLINE BEECHAM, HUMAN GENOME SCIENCES, AND MERCK KGAA SIGN MEMORANDUM OF INTENT FOR GENOMICS AGREEMENT

Record details

Human Genome says it plans to license database to Merck.

• Source: The Wall Street Journal Western Edition. 1996, pages. ) 6(

Record details

METRO FIRMS.

• Authors : Bear, Virginia

• Source: The Washington Times (Washington, DC). 1996, pages. 9

Record details

SB forges R&D deals with Merck KGaA & Takeda

Subjects: SmithKline Beecham Corp. -- Contracts -- 00307917; Merck KGaA -- Contracts; Takeda Chemical Industries Ltd. -- Contracts

• Source: SCRIP World Pharmaceutical News. April 26, 1996 Issue 2123, p11, 1 p.

Record details

Merck lifted net 38% in '95; sees 30% to 40% rise in '96

• Source: Wall Street Journal. Europe. April 30, 1996, Vol. 14, Issue 63, p5, 1 p.

Record details

Merck lifted net 38% in '95; sees 30% to 40% rise in '96

Subjects: Merck KGAA -- Finance; Chemical industry -- Finance; Banking, finance and accounting industries

• Source: Wall Street Journal. Europe. April 30, 1996, Vol. 14 Issue 63, p5, 1 p.

Record details

Merck lifted net 38% in '95; sees 30% to 40% rise in '96.

• Source: Wall Street Journal. Europe. 1996, Vol. v14, Issue n63, pages. 1

Record details

Merck KGaA records 38% profit growth

Subjects: Merck KGAA -- Finance; Pharmaceutical industry -- Finance; Medical equipment and supplies industry -- Finance

• Source: Clinica. May 7, 1996 Issue 704, p9, 1 p.

Record details

Merck KGaA records 38% profit growth.

• Source: Clinica. 1996, Issue n704, pages. 1

Record details

Merck KGaA seeks new acquisitions

Subjects: Merck KGAA -- Mergers, acquisitions and divestments; Pharmaceutical industry -- Mergers, acquisitions and divestments; Business

• Source: Pharmaceutical Business News. May 10, 1996, Vol. 12 Issue 267, p3, 2 p.

Record details

Merck KGaA seeks new acquisitions.

• Source: Pharmaceutical Business News. 1996, Vol. v12, Issue n267, pages. 2

Record details

IMCLONE SYSTEMS AND MERCK KGaA EXTEND COLLABORATION FOR THERAPEUTIC CANCER VACCINES

• Source: Business Wire. May 16, 1996 p5161079.

Record details

IMCLONE SYSTEMS AND MERCK KGaA EXTEND COLLABORATION FOR THERAPEUTIC CANCER VACCINES.

• Source: Business Wire. 1996.

Record details

IMCLONE SYSTEMS AND MERCK KGaA EXTEND COLLABORATION FOR THERAPEUTIC CANCER VACCINES

Record details

Generics/imaging ops lift Merck KGaA

Subjects: Merck KGaA -- Finance; Finance; Marketing

• Source: SCRIP World Pharmaceutical News. May 17, 1996 Issue 2129, p12, 1 p.

Record details

ImClone Systems' BEC-2 shows significant patient survival in the treatment of long-term small cell lung cancer

• Source: Business Wire. May 20, 1996 p5201159.

Record details

ImClone Systems' BEC-2 shows significant patient survival in the treatment of long-term small cell lung cancer.

• Source: Business Wire. 1996.

Record details

Merck KGaA's diagnostics sales fall 2%

Subjects: Merck KGAA -- Finance; Diagnostic reagents industry -- Finance; Business

• Source: Clinica. May 20, 1996 Issue 706, p11, 1 p.

Record details

Merck KGaA's diagnostics sales fall 2%.

• Source: Clinica. 1996, Issue n706, pages. 1

Record details

ImClone Systems' BEC-2 shows significant patient survival in the treatment of long-term small cell lung cancer

Record details

Merck KGaA buys Seven Seas

Subjects: Merck KGaA -- Mergers, acquisitions and divestments; Seven Seas -- Mergers, acquisitions and divestments; Mergers, acquisitions and divestments

• Source: SCRIP World Pharmaceutical News. May 31, 1996 Issue 2133-4, pS1, 1 p.

Record details

Very briefly

• Source: International Herald Tribune. June 21, 1996 p17.

Record details

Merck buys specialist lab company

Subjects: Merck KGAA -- Mergers, acquisitions and divestments; Willi Fischer -- Mergers, acquisitions and divestments; Medical equipment and supplies industry -- Mergers, acquisitions and divestments

• Source: Clinica. June 24, 1996 Issue 711, p9, 1 p.

Record details

Merck buys specialist lab company.

• Source: Clinica. 1996, Issue n711, pages. 1

Record details

Human Genome sets more collaborations in gene development.

• Source: The Wall Street Journal Western Edition. 1996, pages. ) 6(

Record details